Z22.31

Clinical Causes: Carriage of Neisseria meningitidis bacteria (meningococci) in the respiratory or nasopharyngeal mucosa. Close contact with someone who is an active carrier or infected with meningococci. Living in crowded conditions such as dormitories, military barracks, or shelters, which facilitate bacterial spread. Traveling to areas with high prevalence of meningococcal carriage or disease. Having a compromised immune system, making colonization easier.

Key Symptoms: Most carriers do not show any symptoms and are asymptomatic. Some may experience mild symptoms such as sore throat or nasal congestion, but these are not indicative of active disease. Potential for asymptomatic shedding, which means bacteria can be transmitted to others during everyday interactions.

Diagnosis Path: Diagnosis of carrier status involves microbiological testing, often through swab samples from the nasopharynx. Laboratory cultures or PCR tests are used to detect the presence of meningococcal bacteria. Since carriers are asymptomatic, screening is usually performed in specific contexts, like outbreak investigations or close contact assessments.

Treatment Protocols: Asymptomatic carriers typically do not require treatment unless there's a risk of spreading infection during an outbreak. When necessary, antibiotics such as rifampin, ciprofloxacin, or ceftriaxone may be administered to eliminate bacterial carriage among close contacts. Vaccination strategies may also be employed to reduce carriage rates and protect vulnerable populations.